Reports effectiveness and safety of risankizumab specifically in East Asian participants from global phase 2b/3 UC trials, which may inform regional applicability of trial results for people with moderate-to-severe...

This case highlights that full-thickness rectal prolapse in a toddler can be caused by very early-onset ulcerative colitis rather than isolated pediatric prolapse or allergy.

Based on the title and source metadata, this appears to be a clinical study related to Inflammatory bowel disease, Vedolizumab, and Anti Integrin. The original article is from gastroendonews.com.

A patient describes recovering from severe Crohn’s-related malnutrition and living with an ileostomy, then regaining weight and muscle after reversal—topics many people with IBD face. The story highlights practical...

Personal stories can reduce isolation and show that people with Crohn’s disease—including high-level athletes—manage their condition and return to activities they care about. This can be encouraging and raise public...

Perianal fistulas are a challenging complication of Crohn’s disease with limited effective options; a phase 3 trial reports that guselkumab improved fistula remission rates through 48 weeks, which could offer a new...

IBD is linked to higher skeletal risk; early biochemical changes in Wnt-pathway proteins might identify bone impairment before DXA detects low bone density, potentially helping earlier risk stratification.

Based on the title and source metadata, this appears to be a case report related to Ulcerative colitis, Inflammatory bowel disease, and Complications. The original article is from Middle East journal of digestive...

If you have moderate-to-severe UC and are treated with adalimumab (or other therapies), this study suggests the rectum may be slower or less likely to reach endoscopic and histologic healing than more proximal colon...

The review evaluates a revised preprint linking GM-CSF, macrophages, and ILC-like cells in Crohn’s disease using human spatial transcriptomics and zebrafish experiments. It highlights limitations that matter because they...

Based on the title and source metadata, this appears to be a market or business news related to Research and clinical trials. The original article is from thepharmaletter.com.

Based on the title and source metadata, this appears to be a patient story related to Community and awareness. The original article is from pressreader.com.

Personal recovery stories can offer hope and practical ideas for people with Crohn’s who are dealing with malnutrition, body-image issues, ostomy surgery, or post-surgical recovery.

New mouse-model research identifies TIMD4-dependent macrophage pathways that influence monocyte recruitment and colitis severity and tests a TIMD4-derived peptide delivered in nanoparticles that reduced inflammation in...

Stories like this highlight how Crohn’s can be misattributed to stress—especially for women—and the emotional, educational, and physical toll of delayed diagnosis and prolonged flares. They can help others recognise...

These patient-derived human tissue models aim to let drug developers test whether a candidate affects disease-relevant biology in human intestinal tissue before moving to clinical trials, which could help reduce failures...

This mid‑stage trial reports strong week‑44 clinical remission and endoscopic response rates for duvakitug, an investigational anti‑TL1A therapy, in both UC and Crohn’s disease — a development that could expand future...

New Phase III data on guselkumab are directly relevant because they report long-term (3-year) maintenance results for Crohn’s disease and one-year fistula outcomes for people with perianal disease — areas that affect...

Personal stories like this show how surgery, nutrition, and tailored exercise can help someone with Crohn’s rebuild strength, body weight, and confidence. They can offer practical ideas and emotional encouragement to...

Based on the title and source metadata, this appears to be a clinical study related to Inflammatory bowel disease and Tests and monitoring. The original article is from Middle East journal of digestive diseases.

Based on the title and source metadata, this appears to be a clinical study related to Inflammatory bowel disease, Ustekinumab, and IL-12/23 inhibitor. The original article is from Gastro hep advances.

Long-term risk of needing another intestinal surgery is a major concern for people with Crohn’s disease. This study suggests laparoscopic resection may be linked to lower long-term reoperation risk compared with open...

Early intestinal resection is uncommon but important in pediatric Crohn’s disease. Identifying features linked to surgery soon after diagnosis can help families and clinicians monitor higher-risk children and plan care.

Stronger, more sustainable IBD research units can increase patient access to clinical studies, speed up therapeutic and biomarker advances, and make care more research-ready. Patients and clinicians in centers with...

Based on the title and source metadata, this appears to be a patient education related to Ulcerative colitis, Inflammatory bowel disease, and Tests and monitoring. The original article is from Crohn's & colitis 360.

This review connects enteric sensory neuron dysfunction to symptoms common in IBS and IBD (pain, diarrhea, constipation, dysmotility). Understanding IPAN plasticity could point to new treatment targets that act locally...

Self-management is central to long-term IBD control. The study shows many patients have limited disease knowledge and less favorable attitudes, which could affect adherence, lifestyle choices, and follow-up.

Postoperative recurrence in Crohn's disease is common and often first detected on endoscopy. If probiotics reduced endoscopic recurrence, it could offer a low-risk, non-pharmacologic strategy to help prevent disease...

Children with Crohn’s disease may have vitamin D deficiency and a theoretical link between vitamin D levels and relapse risk; this trial tested whether adding high‑dose vitamin D3 at diagnosis could lower relapses and...

Distinguishing inflammation from irreversible fibrosis is a common clinical challenge in Crohn’s disease because it affects treatment choices (medical therapy versus surgery). Validated MRI biomarkers could improve...

Cure8 found this source from chicagobusiness.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Risankizumab. Open the original article for the full...

The study suggests Crohn’s disease is associated with coordinated brain structure and function differences that relate to disease activity and quality of life, pointing to brain–gut links that could inform future...

Staying on an immunomodulator with anti-TNF therapy was linked to greater long-term persistence of the biologic drug, which matters because loss of response to anti-TNF agents is a common problem in Crohn’s disease....

People with Crohn’s disease facing pelvic exenteration or urinary diversion may worry that using ileal tissue is unsafe. This study suggests ileal conduits can be done but carry higher urological complication and...

Findings suggest a dietary flavonoid (daidzein) may reduce colitis in mice via microbial activation and host signaling pathways, pointing toward microbiome-informed nutritional approaches for IBD.

Identifying genes and pathways involved in IBD can point to new biological mechanisms, potential biomarkers, and future targets for research that may eventually inform diagnosis or treatment.

The review identifies berberine as a potential adjunct therapy for UC because it may target both gut microbes and epithelial inflammasome-mediated cell death, processes important in disease activity and barrier function.

Based on the title and source metadata, this appears to be a basic science related to Ulcerative colitis, Inflammatory bowel disease, and Research and clinical trials. The original article is from Inflammopharmacology.

This study reports that an optimized Cycas revoluta leaf extract reduced colon inflammation and markers of oxidative stress in a rat model of ulcerative colitis, suggesting it could be a source of bioactive compounds...

The article offers an Ayurvedic framework for understanding and managing ulcerative colitis that may interest patients seeking complementary approaches and clinicians exploring integrative care. It emphasizes dietary and...

If true, a commonly available dietary change—drinking alkalinised filtered water—might modestly affect inflammatory markers and specific gut bacteria in people with IBD in remission, which could be of interest to...

Patients and clinicians may care because the investigational drug duvakitug reportedly sustained clinical and endoscopic benefits through 44 weeks in both ulcerative colitis and Crohn’s disease, which could represent a...

This report documents one‑year outcomes after fecal microbiota transplantation in four very ill children across several indications, including a child with Crohn’s disease and severe C.

Cure8 found this source from tipranks.com, but the page could not be read reliably yet. It is tagged for Research and clinical trials. Open the original article for the full details.

The paper identifies a metabolic pathway (HIF-1α–driven lactylation leading to ferroptosis) that may contribute to epithelial injury in ulcerative colitis and proposes quercetin as a candidate inhibitor—potentially...

This study identifies KCTD10 as a regulator of intestinal stem cell function and mucosal repair in experimental colitis, which could point to new mechanistic insights about why epithelial healing fails in some cases of...

If endometriosis is linked to other immune, allergic, or chronic pain conditions, people with endometriosis may benefit from broader evaluation and coordinated care beyond gynecology. The review suggests shared...

Perianal fistulizing Crohn's disease is a frequent, hard-to-treat complication; molecular and multiomic advances could lead to biomarkers that help choose better-targeted therapies and improve surgical–medical decision...